Antipsychotic Trials in Schizophrenia(English, Hardcover, unknown)

Antipsychotic Trials in Schizophrenia(English, Hardcover, unknown)

  • unknown
Publisher:Cambridge University PressISBN 13: 9780521895330ISBN 10: 0521895332

Paperback & Hardcover deals ―

Amazon IndiaGOFlipkart ₹ 14000SnapdealGOSapnaOnlineGOJain Book AgencyGOBooks Wagon₹1,952Book ChorGOCrosswordGODC BooksGO

e-book & Audiobook deals ―

Amazon India GOGoogle Play Books GOAudible GO

* Price may vary from time to time.

* GO = We're not able to fetch the price (please check manually visiting the website).

Know about the book -

Antipsychotic Trials in Schizophrenia(English, Hardcover, unknown) is written by unknown and published by Cambridge University Press. It's available with International Standard Book Number or ISBN identification 0521895332 (ISBN 10) and 9780521895330 (ISBN 13).

Antipsychotic medications are a key treatment for schizophrenia and sales of antipsychotic drugs approach $20 billion per year, with fierce marketing between the makers of the drugs. The U.S. National Institute of Mental Health sponsored the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project to provide independent information about the comparative effectiveness of medications. CATIE was the largest, longest and most comprehensive study of schizophrenia to date. Conducted under rigorous double-blind conditions, Antipsychotic Trials in Schizophrenia presents the definitive archival results of this landmark study. The core of the book consists of chapters focused on specific outcomes that set the CATIE findings in a wider context. Also included are chapters on the design, statistical analyses and implications for researchers, clinicians and policy makers. Psychiatrists, psychiatric researchers, mental health policy makers and those working in pharmaceutical companies will all find this to be essential reading.